Cystotech Invest ApS: Financial statements 2023
CVR: 43238191
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Cystotech Invest ApS (CVR 43238191) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -21,520 and a net result of DKK -21,520. Equity in the 2023 report amounted to DKK 5,413,398. The solvency ratio was 99.9%.
- Gross Profit
- DKK -21,520
- Profit/Loss
- DKK -21,520
- Equity
- DKK 5,413,398
- Total Assets
- DKK 5,420,148
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of August 24, 2023, POUL CARSTENSEN HOLDING ApS is registered as an owner of Cystotech Invest ApS with an ownership share of 10%.
Cystotech Invest ApS has published its interim report for the period May 4, 2022 to December 31, 2022.
About Cystotech Invest ApS
Cystotech Invest ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2022. The company is registered under the industry Investering for egen regning. The management consists of Morten Petersen. The board consists of Bo Wase, Flemming Frandsen, Morten Petersen and Ole Niels Jakob Jensen. The company's owners include WAP HOLDING ApS, MORTEN PETERSEN ApS and POUL CARSTENSEN HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -24,281 and a net result of DKK -24,281 compared with DKK -14,849 the year before. Equity in the 2025 report amounted to DKK 8,804,268.
